Marcus Wilson, Pharm.D. is president of HealthCore, a wholly owned subsidiary of WellPoint, Inc. HealthCore utilizes the vast world research environment provided by WellPoint's national reach and local depth to provide research service focused on clinical effectiveness, health economics and safety evaluation of various healthcare interventions. The results of the studies offer clarity that empowers a broad array of healthcare decision makers to act with precision to improve quality, safety and affordability.
Dr. Wilson received his doctor of pharmacy degree from VCU/Medical College of Virginia and joined the faculty of the University of Sciences in Philadelphia after completing his residency. While on the University of the Sciences in Philadelphia faculty, he developed an outcomes research and patient education division within the HealthCare Centers of Christiana, a wholly-owed division of Blue Cross Blue Shield of Delaware (BCBSD). The program assets were later purchased from BCBSD and used to found HealthCore. Much of his work has focused upon assessing the value (benefit versus cost) and safety of various healthcare products, services and programs including pharmaceuticals, biotechnologies, medical devices and disease management programs in the real world setting.
In addition to his leadership position with HealtCore, he also serves on several WellPoint committees including the Strategy & Innovations Council, the Information Management Steering Committee and the Public Policy Steering Committee. He is a past member of the board of directors of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR) and is a reviewer for multiple journals. His publications, including book chapters, span various clinical and health outcomes topics.